RIFAMPIN

RIFAMPIN was reported 14916 times

RIFAMPIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TYPE 2 LEPRA REACTION 61 0.3262
1 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 100 0.2985
2 MYCOBACTERIUM ULCERANS INFECTION 16 0.2807
3 CYSTIC FIBROSIS PANCREATIC 9 0.2000
4 TYPE 1 LEPRA REACTION 10 0.1961
5 ATYPICAL MYCOBACTERIUM TEST POSITIVE 18 0.1856
6 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 32 0.1758
7 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 12 0.1667
8 ANTICOAGULATION DRUG LEVEL DECREASED 17 0.1405
9 TUBERCULOSIS OF EYE 9 0.1286
10 PIGMENT NEPHROPATHY 11 0.1236
11 MYCOBACTERIUM AVIUM COMPLEX INFECTION 298 0.1109
12 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 29 0.1070
13 PARADOXICAL DRUG REACTION 390 0.1059
14 MULTIPLE DRUG HYPERSENSITIVITY 10 0.1042
15 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 22 0.0995
16 BILE ACIDS INCREASED 17 0.0960
17 OLIGOARTHRITIS 19 0.0955
18 MYCOBACTERIUM HAEMOPHILUM INFECTION 25 0.0874
19 INTERFERON GAMMA RELEASE ASSAY POSITIVE 14 0.0854
20 HYPOPROTHROMBINAEMIA 23 0.0764
21 ACID FAST BACILLI INFECTION 11 0.0683
22 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 9 0.0634
23 MYCOBACTERIUM TEST POSITIVE 13 0.0631
24 CHOROIDITIS 23 0.0615
25 MYCOBACTERIAL INFECTION 103 0.0597
26 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 27 0.0578
27 MYCOBACTERIUM KANSASII INFECTION 9 0.0549
28 ALOPECIA SCARRING 10 0.0546
29 MENINGITIS TUBERCULOUS 29 0.0519
30 CARDIAC VALVE VEGETATION 25 0.0514
31 VOGT-KOYANAGI-HARADA DISEASE 11 0.0500
32 CUTANEOUS TUBERCULOSIS 9 0.0495
33 PANCREATITIS HAEMORRHAGIC 22 0.0474
34 ALVEOLAR LUNG DISEASE 9 0.0474
35 DISSEMINATED TUBERCULOSIS 112 0.0436
36 MYCOBACTERIUM ABSCESSUS INFECTION 31 0.0434
37 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 215 0.0431
38 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 13 0.0421
39 OEDEMATOUS KIDNEY 11 0.0415
40 ATYPICAL MYCOBACTERIAL INFECTION 57 0.0403
41 PULMONARY CAVITATION 33 0.0379
42 TUBERCULOSIS GASTROINTESTINAL 12 0.0376
43 VASCULAR PURPURA 52 0.0372
44 TOXIC OPTIC NEUROPATHY 16 0.0369
45 URINARY TRACT INFLAMMATION 13 0.0361
46 JARISCH-HERXHEIMER REACTION 25 0.0351
47 SPLENIC ABSCESS 13 0.0319
48 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 38 0.0317
49 ACCELERATED HYPERTENSION 12 0.0317
50 LATENT TUBERCULOSIS 66 0.0315
51 CONDUCTIVE DEAFNESS 10 0.0312
52 OPTIC NEUROPATHY 65 0.0307
53 EXTRAPULMONARY TUBERCULOSIS 9 0.0305
54 OEDEMATOUS PANCREATITIS 17 0.0303
55 INFECTIVE ANEURYSM 15 0.0303
56 CAT SCRATCH DISEASE 12 0.0299
57 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 765 0.0297
58 LYMPH NODE TUBERCULOSIS 21 0.0282
59 CENTRAL NERVOUS SYSTEM VASCULITIS 14 0.0275
60 VITAMIN K DEFICIENCY 11 0.0274
61 THALAMIC INFARCTION 16 0.0270
62 PULMONARY TUBERCULOSIS 112 0.0262
63 BONE TUBERCULOSIS 10 0.0261
64 OTOTOXICITY 48 0.0259
65 LOWER URINARY TRACT SYMPTOMS 9 0.0249
66 MYCOBACTERIUM MARINUM INFECTION 8 0.0246
67 PNEUMATOSIS INTESTINALIS 68 0.0238
68 MECHANICAL URTICARIA 11 0.0235
69 PYROGLUTAMIC ACIDOSIS 9 0.0227
70 MULTIPLE-DRUG RESISTANCE 70 0.0226
71 TUBERCULOUS PLEURISY 10 0.0211
72 ANTIPSYCHOTIC DRUG LEVEL DECREASED 11 0.0207
73 OCULAR TOXICITY 22 0.0199
74 SKIN CANDIDA 10 0.0192
75 SPUTUM CULTURE POSITIVE 15 0.0185
76 DRUG RESISTANCE 474 0.0184
77 GLOMERULONEPHRITIS MINIMAL LESION 13 0.0179
78 EOSINOPHILIC PNEUMONIA 55 0.0174
79 LABELLED DRUG-DRUG INTERACTION ISSUE 25 0.0173
80 INCREASED VISCOSITY OF BRONCHIAL SECRETION 11 0.0172
81 HYPERMETABOLISM 9 0.0170
82 METHAEMOGLOBINAEMIA 39 0.0168
83 NEUROPSYCHOLOGICAL SYMPTOMS 10 0.0166
84 TYPE IV HYPERSENSITIVITY REACTION 45 0.0164
85 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 38 0.0160
86 SEPTIC EMBOLUS 13 0.0156
87 FRACTURE PAIN 8 0.0148
88 IMMUNE RECONSTITUTION SYNDROME 19 0.0147
89 INTERTRIGO 8 0.0147
90 HIDRADENITIS 134 0.0147
91 DYSCHROMATOPSIA 12 0.0145
92 PSOAS ABSCESS 9 0.0144
93 ADRENOCORTICAL INSUFFICIENCY ACUTE 28 0.0143
94 SPUTUM RETENTION 14 0.0141
95 FOCAL DYSCOGNITIVE SEIZURES 16 0.0140
96 HEPATIC CYTOLYSIS 176 0.0138
97 OSTEOGENESIS IMPERFECTA 8 0.0137
98 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 15 0.0136
99 MYCOBACTERIUM CHELONAE INFECTION 10 0.0135
100 CHOLESTATIC LIVER INJURY 30 0.0135
101 SPUTUM INCREASED 28 0.0129
102 CHRONIC ALLOGRAFT NEPHROPATHY 10 0.0128
103 LINEAR IGA DISEASE 21 0.0126
104 RED MAN SYNDROME 11 0.0125
105 DRUG LEVEL DECREASED 126 0.0124
106 DISTRIBUTIVE SHOCK 28 0.0124
107 EOSINOPHILIA 209 0.0119
108 CRYPTOCOCCOSIS 19 0.0116
109 BRONCHIECTASIS 78 0.0116
110 EXTRADURAL ABSCESS 9 0.0115
111 HILAR LYMPHADENOPATHY 10 0.0114
112 GRANULOMATOUS LIVER DISEASE 8 0.0114
113 GRANULOMA 39 0.0113
114 DRUG-INDUCED LIVER INJURY 353 0.0112
115 RENAL TRANSPLANT FAILURE 11 0.0111
116 RASH MORBILLIFORM 30 0.0108
117 PATHOGEN RESISTANCE 98 0.0107
118 LIVER TRANSPLANT 39 0.0107
119 RENAL TUBULAR INJURY 13 0.0107
120 DERMATITIS EXFOLIATIVE GENERALISED 37 0.0106
121 HYPERSENSITIVITY PNEUMONITIS 12 0.0105
122 TRISOMY 21 13 0.0103
123 HYPERTRANSAMINASAEMIA 69 0.0099
124 RESPIRATORY SYMPTOM 28 0.0098
125 DYSBIOSIS 8 0.0097
126 CULTURE POSITIVE 8 0.0096
127 HYDROCEPHALUS 52 0.0095
128 HEPATIC HAEMORRHAGE 8 0.0093
129 CUTANEOUS VASCULITIS 34 0.0093
130 FIXED ERUPTION 16 0.0093
131 ENTEROVIRUS INFECTION 8 0.0093
132 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 69 0.0092
133 GLOMERULAR FILTRATION RATE ABNORMAL 13 0.0092
134 INTERVERTEBRAL DISCITIS 17 0.0090
135 PREGNANCY WITH IMPLANT CONTRACEPTIVE 42 0.0089
136 HEPATOTOXICITY 198 0.0089
137 NEUROPSYCHIATRIC SYMPTOMS 8 0.0089
138 STAPHYLOCOCCAL BACTERAEMIA 38 0.0087
139 VIROLOGIC FAILURE 47 0.0087
140 DIFFUSE ALVEOLAR DAMAGE 10 0.0087
141 ACUTE HEPATIC FAILURE 116 0.0085
142 HEPATITIS CHOLESTATIC 51 0.0085
143 PNEUMOCYSTIS JIROVECII INFECTION 10 0.0084
144 TUBULOINTERSTITIAL NEPHRITIS 156 0.0083
145 PRETERM PREMATURE RUPTURE OF MEMBRANES 10 0.0083
146 LYMPHADENITIS 20 0.0083
147 NORMOCYTIC ANAEMIA 12 0.0082
148 IMMUNE THROMBOCYTOPENIA 37 0.0081
149 OPTIC NEURITIS 73 0.0080
150 RASH MACULO-PAPULAR 178 0.0080
151 BRAIN ABSCESS 20 0.0079
152 DIABETES INSIPIDUS 19 0.0079
153 MAST CELL ACTIVATION SYNDROME 11 0.0078
154 HENOCH-SCHONLEIN PURPURA 17 0.0078
155 RENAL TUBULAR NECROSIS 75 0.0076
156 ENDOCARDITIS 39 0.0076
157 LUNG CONSOLIDATION 21 0.0075
158 DRUG LEVEL BELOW THERAPEUTIC 41 0.0074
159 SYNOVIAL CYST 34 0.0074
160 INFECTIOUS PLEURAL EFFUSION 11 0.0072
161 PRODUCT USED FOR UNKNOWN INDICATION 9 0.0071
162 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19 0.0071
163 DRUG INTERACTION 1133 0.0071
164 WHITE MATTER LESION 9 0.0071
165 IDIOPATHIC INTRACRANIAL HYPERTENSION 16 0.0071
166 SUBCUTANEOUS HAEMATOMA 9 0.0070
167 CENTRAL NERVOUS SYSTEM INFECTION 8 0.0070
168 HEPATITIS TOXIC 18 0.0069
169 PNEUMONIA LEGIONELLA 11 0.0069
170 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 9 0.0068
171 PULMONARY TOXICITY 48 0.0068
172 RESPIRATORY ALKALOSIS 11 0.0068
173 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 59 0.0067
174 HEPATIC ENCEPHALOPATHY 61 0.0065
175 TYPE I HYPERSENSITIVITY 23 0.0065
176 HEPATORENAL SYNDROME 11 0.0065
177 DEAFNESS BILATERAL 11 0.0065
178 BILIRUBIN CONJUGATED INCREASED 15 0.0064
179 HEPATITIS FULMINANT 19 0.0064
180 ASPERGILLUS INFECTION 42 0.0064
181 GASTROINTESTINAL STOMA COMPLICATION 10 0.0064
182 WOUND INFECTION STAPHYLOCOCCAL 11 0.0064
183 NEPHRITIS INTERSTITIAL 8 0.0063
184 LICHENOID KERATOSIS 14 0.0061
185 OXYGEN THERAPY 10 0.0061
186 HYPOVITAMINOSIS 8 0.0060
187 SKIN INDURATION 12 0.0058
188 LIVEDO RETICULARIS 12 0.0057
189 SPLENIC INFARCTION 10 0.0057
190 FUNGAEMIA 9 0.0057
191 OPHTHALMOPLEGIA 9 0.0057
192 HAEMOLYTIC ANAEMIA 51 0.0057
193 MIXED LIVER INJURY 17 0.0056
194 CHOLESTASIS 108 0.0056
195 LIVER TRANSPLANT REJECTION 10 0.0056
196 OPTIC ATROPHY 9 0.0055
197 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 300 0.0055
198 DEPRESSIVE SYMPTOM 19 0.0054
199 OSTEOLYSIS 11 0.0054
200 LUNG OPACITY 14 0.0053
201 HYPERLACTACIDAEMIA 14 0.0052
202 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 8 0.0052
203 ENCEPHALITIS 36 0.0052
204 SPUTUM DISCOLOURED 49 0.0052
205 COAGULOPATHY 86 0.0052
206 HYPERBILIRUBINAEMIA 53 0.0051
207 JAUNDICE CHOLESTATIC 18 0.0051
208 HEPATOSPLENOMEGALY 13 0.0051
209 CELL DEATH 10 0.0050
210 NOSOCOMIAL INFECTION 11 0.0050
211 AUTOIMMUNE HAEMOLYTIC ANAEMIA 17 0.0050
212 PSEUDOMEMBRANOUS COLITIS 11 0.0049
213 DYSLIPIDAEMIA 25 0.0049
214 DEAFNESS NEUROSENSORY 16 0.0049
215 RECALLED PRODUCT ADMINISTERED 46 0.0048
216 EOSINOPHIL COUNT INCREASED 40 0.0048
217 MULTIPLE ORGAN DYSFUNCTION SYNDROME 135 0.0048
218 ENTEROBACTER INFECTION 8 0.0048
219 KLEBSIELLA INFECTION 24 0.0047
220 DRUG INTOLERANCE 441 0.0046
221 TRANSAMINASES INCREASED 101 0.0045
222 THROMBOTIC THROMBOCYTOPENIC PURPURA 16 0.0045
223 LYME DISEASE 15 0.0045
224 HEPATITIS 114 0.0045
225 HAEMOPTYSIS 124 0.0044
226 PSEUDOMONAS INFECTION 38 0.0044
227 NOCARDIOSIS 11 0.0043
228 SKIN HYPERTROPHY 12 0.0043
229 STAPHYLOCOCCUS TEST POSITIVE 9 0.0043
230 HEPATIC NECROSIS 16 0.0042
231 HYPERAMMONAEMIA 21 0.0042
232 INTERNATIONAL NORMALISED RATIO DECREASED 17 0.0042
233 NEPHROPATHY TOXIC 47 0.0042
234 LYMPHADENOPATHY MEDIASTINAL 8 0.0042
235 WOUND DEHISCENCE 14 0.0041
236 HYPERURICAEMIA 17 0.0041
237 PERICARDIAL HAEMORRHAGE 9 0.0041
238 CACHEXIA 21 0.0041
239 TOOTH DISCOLOURATION 12 0.0041
240 TREATMENT FAILURE 337 0.0041
241 PNEUMONIA FUNGAL 16 0.0041
242 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
243 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 10 0.0040
244 PNEUMONIA BACTERIAL 37 0.0040
245 JAUNDICE 108 0.0040
246 HEPATOCELLULAR DAMAGE 9 0.0040
247 COMPUTERISED TOMOGRAM ABNORMAL 9 0.0040
248 SKIN HYPERPIGMENTATION 34 0.0040
249 TUBERCULIN TEST POSITIVE 10 0.0039
250 LOW BIRTH WEIGHT BABY 31 0.0039
251 OLIGOHYDRAMNIOS 13 0.0039
252 NEPHROGENIC ANAEMIA 18 0.0039
253 ARTHRITIS INFECTIVE 18 0.0039
254 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 30 0.0039
255 PULMONARY MASS 57 0.0038
256 ALANINE AMINOTRANSFERASE ABNORMAL 8 0.0038
257 FOETAL GROWTH RESTRICTION 23 0.0038
258 MYOPIA 9 0.0038
259 HAEMOLYSIS 29 0.0038
260 LONG QT SYNDROME 9 0.0037
261 OCULAR ICTERUS 16 0.0037
262 STAPHYLOCOCCAL INFECTION 120 0.0036
263 DISSEMINATED INTRAVASCULAR COAGULATION 51 0.0036
264 DRUG ERUPTION 64 0.0036
265 TOXIC SKIN ERUPTION 36 0.0036
266 LUNG INFILTRATION 31 0.0035
267 PURPURA 31 0.0035
268 BLOOD CREATININE ABNORMAL 12 0.0035
269 UNINTENDED PREGNANCY 36 0.0034
270 MENINGITIS 23 0.0034
271 HYPERSENSITIVITY VASCULITIS 9 0.0034
272 ARTHRITIS BACTERIAL 14 0.0034
273 NYSTAGMUS 18 0.0034
274 ACUTE RESPIRATORY FAILURE 65 0.0034
275 LIVER INJURY 82 0.0033
276 AGRANULOCYTOSIS 62 0.0033
277 HALLUCINATIONS, MIXED 14 0.0033
278 HYPERCAPNIA 10 0.0033
279 TOXIC EPIDERMAL NECROLYSIS 50 0.0033
280 BLOOD URIC ACID INCREASED 19 0.0033
281 AORTIC VALVE INCOMPETENCE 14 0.0033
282 PRODUCTIVE COUGH 157 0.0033
283 ABSCESS LIMB 14 0.0033
284 AUTOIMMUNE DISORDER 32 0.0033
285 VIRAL MUTATION IDENTIFIED 12 0.0033
286 BLOOD PRESSURE SYSTOLIC ABNORMAL 8 0.0032
287 OLIGURIA 20 0.0032
288 BACTERAEMIA 38 0.0032
289 ACUTE RESPIRATORY DISTRESS SYNDROME 56 0.0032
290 OSTEOMYELITIS 57 0.0031
291 SUBCUTANEOUS ABSCESS 15 0.0031
292 COMA SCALE ABNORMAL 9 0.0031
293 ENTEROCOCCAL INFECTION 15 0.0031
294 BRONCHOPULMONARY ASPERGILLOSIS 24 0.0031
295 LIVER ABSCESS 10 0.0031
296 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0031
297 SPLENOMEGALY 36 0.0031
298 WOUND SECRETION 12 0.0031
299 PEMPHIGOID 23 0.0030
300 LYMPHOPENIA 43 0.0030
301 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 29 0.0030
302 PREMATURE DELIVERY 48 0.0030
303 ABSCESS 48 0.0030
304 DERMATITIS EXFOLIATIVE 15 0.0030
305 EAR CONGESTION 8 0.0029
306 PRODUCT PRESCRIBING ISSUE 63 0.0029
307 MACULE 8 0.0029
308 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
309 FISTULA 32 0.0028
310 NECROTISING FASCIITIS 10 0.0028
311 ACUTE KIDNEY INJURY 434 0.0028
312 STAPHYLOCOCCAL SEPSIS 14 0.0028
313 DEAFNESS 74 0.0028
314 RHINOVIRUS INFECTION 11 0.0028
315 MACULOPATHY 10 0.0028
316 LYMPHADENOPATHY 99 0.0028
317 ENTEROCOLITIS 16 0.0028
318 BRAIN OEDEMA 35 0.0028
319 OESOPHAGEAL CANDIDIASIS 11 0.0028
320 LUPUS-LIKE SYNDROME 25 0.0028
321 BLOOD BILIRUBIN INCREASED 74 0.0027
322 THERAPY NON-RESPONDER 123 0.0027
323 ONYCHOMYCOSIS 12 0.0027
324 HEPATIC FUNCTION ABNORMAL 102 0.0027
325 LEUKOPENIA 136 0.0027
326 THROMBOCYTOPENIA 303 0.0027
327 ORAL CANDIDIASIS 35 0.0027
328 CHROMATURIA 60 0.0027
329 SERUM FERRITIN INCREASED 14 0.0027
330 MUCOUS STOOLS 13 0.0026
331 ORGANISING PNEUMONIA 13 0.0026
332 DRUG LEVEL ABOVE THERAPEUTIC 12 0.0026
333 INTERNATIONAL NORMALISED RATIO ABNORMAL 9 0.0026
334 PANCYTOPENIA 146 0.0026
335 ANAL ABSCESS 14 0.0026
336 C-REACTIVE PROTEIN INCREASED 94 0.0026
337 SHOCK HAEMORRHAGIC 21 0.0026
338 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
339 TOXIC ENCEPHALOPATHY 13 0.0026
340 ENCEPHALOPATHY 63 0.0026
341 THERAPY PARTIAL RESPONDER 40 0.0026
342 SECRETION DISCHARGE 32 0.0026
343 SKIN ODOUR ABNORMAL 10 0.0025
344 LEUKOCYTOSIS 46 0.0025
345 IRIDOCYCLITIS 8 0.0025
346 NODULE 33 0.0025
347 HEPATIC FAILURE 76 0.0025
348 HYPERTENSIVE CRISIS 28 0.0025
349 NECROSIS 14 0.0025
350 APHONIA 35 0.0025
351 PANCREATITIS ACUTE 56 0.0025
352 VASCULITIS 29 0.0025
353 METABOLIC ACIDOSIS 79 0.0025
354 POLYARTHRITIS 13 0.0025
355 PRODUCT USE IN UNAPPROVED INDICATION 605 0.0024
356 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 25 0.0024
357 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 8 0.0024
358 GENERALISED TONIC-CLONIC SEIZURE 40 0.0024
359 PETECHIAE 25 0.0024
360 PROTHROMBIN TIME PROLONGED 14 0.0023
361 NEPHROTIC SYNDROME 16 0.0023
362 SKIN LESION 64 0.0023
363 ASPARTATE AMINOTRANSFERASE INCREASED 121 0.0023
364 CARDIAC VALVE DISEASE 13 0.0023
365 POLYNEUROPATHY 27 0.0023
366 LACTIC ACIDOSIS 73 0.0023
367 AZOTAEMIA 9 0.0023
368 SKIN PLAQUE 19 0.0023
369 ANAL FISSURE 12 0.0022
370 CHEILITIS 12 0.0022
371 DEVICE RELATED INFECTION 34 0.0022
372 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12 0.0022
373 DEMYELINATION 9 0.0022
374 END STAGE RENAL DISEASE 40 0.0022
375 APHTHOUS ULCER 17 0.0022
376 CANDIDA INFECTION 37 0.0022
377 HEPATOCELLULAR INJURY 31 0.0022
378 GENERALISED OEDEMA 27 0.0022
379 AUTISM SPECTRUM DISORDER 12 0.0022
380 PULMONARY HAEMORRHAGE 17 0.0022
381 NEUROTOXICITY 38 0.0022
382 ELECTROCARDIOGRAM QT PROLONGED 78 0.0022
383 TREATMENT NONCOMPLIANCE 118 0.0022
384 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
385 IMMUNODEFICIENCY 32 0.0021
386 PNEUMOTHORAX 34 0.0021
387 REFUSAL OF TREATMENT BY PATIENT 14 0.0021
388 HAEMODIALYSIS 18 0.0021
389 STATUS EPILEPTICUS 24 0.0021
390 PREMATURE LABOUR 12 0.0021
391 SKIN NECROSIS 11 0.0021
392 ALANINE AMINOTRANSFERASE INCREASED 130 0.0021
393 SKIN MASS 14 0.0021
394 CONDITION AGGRAVATED 634 0.0021
395 HEPATIC LESION 9 0.0021
396 VISUAL FIELD DEFECT 15 0.0021
397 ANORECTAL DISCOMFORT 11 0.0021
398 PANIC DISORDER 8 0.0021
399 IMMUNOSUPPRESSION 18 0.0020
400 PSYCHIATRIC SYMPTOM 15 0.0020
401 HEPATITIS ACUTE 13 0.0020
402 INTERNATIONAL NORMALISED RATIO INCREASED 57 0.0020
403 TRANSPLANT REJECTION 16 0.0020
404 DYSPHONIA 116 0.0020
405 ACIDOSIS 15 0.0020
406 CYTOPENIA 24 0.0020
407 ANAPHYLACTOID REACTION 8 0.0019
408 TINNITUS 89 0.0019
409 DRUG LEVEL INCREASED 32 0.0019
410 BLOOD ALKALINE PHOSPHATASE INCREASED 48 0.0019
411 HYPOALBUMINAEMIA 15 0.0019
412 POSTOPERATIVE WOUND INFECTION 13 0.0019
413 RESPIRATORY FAILURE 140 0.0019
414 MALABSORPTION 10 0.0019
415 DISEASE RECURRENCE 91 0.0019
416 SQUAMOUS CELL CARCINOMA 18 0.0019
417 TORSADE DE POINTES 15 0.0019
418 CARDIAC TAMPONADE 9 0.0019
419 STEVENS-JOHNSON SYNDROME 42 0.0019
420 LIP OEDEMA 8 0.0019
421 EMPHYSEMA 19 0.0019
422 NEUTROPENIA 256 0.0019
423 MALNUTRITION 21 0.0019
424 AUTOIMMUNE HEPATITIS 13 0.0019
425 HUMERUS FRACTURE 9 0.0019
426 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
427 REBOUND EFFECT 21 0.0019
428 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 11 0.0019
429 POST PROCEDURAL INFECTION 15 0.0018
430 HAEMODYNAMIC INSTABILITY 14 0.0018
431 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
432 ERYTHEMA MULTIFORME 17 0.0018
433 RHABDOMYOLYSIS 76 0.0018
434 SEROTONIN SYNDROME 35 0.0018
435 PANCREATITIS 96 0.0018
436 SEPTIC SHOCK 79 0.0018
437 ADRENAL INSUFFICIENCY 22 0.0018
438 RENAL IMPAIRMENT 150 0.0018
439 PIGMENTATION DISORDER 11 0.0018
440 BACTERIAL INFECTION 33 0.0018
441 CHOLECYSTITIS ACUTE 10 0.0018
442 LIVER FUNCTION TEST ABNORMAL 51 0.0018
443 GASTROINTESTINAL DISORDER 157 0.0018
444 THERAPY INTERRUPTED 125 0.0017
445 RENAL FAILURE ACUTE 74 0.0017
446 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
447 LYMPHOEDEMA 12 0.0017
448 IRON DEFICIENCY ANAEMIA 16 0.0017
449 PREMATURE BABY 52 0.0017
450 TENDERNESS 18 0.0017
451 PYREXIA 592 0.0017
452 HYPOVOLAEMIA 10 0.0017
453 HEPATIC CIRRHOSIS 32 0.0017
454 TENDON DISORDER 11 0.0017
455 BRONCHOSPASM 24 0.0017
456 NIGHT SWEATS 54 0.0017
457 MENTAL STATUS CHANGES 46 0.0017
458 ATELECTASIS 16 0.0017
459 NORMAL NEWBORN 9 0.0017
460 HEMIPARESIS 28 0.0017
461 FAECES SOFT 12 0.0016
462 PERICARDIAL EFFUSION 38 0.0016
463 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
464 ASCITES 48 0.0016
465 RESPIRATORY DISTRESS 45 0.0016
466 HEPATOMEGALY 16 0.0016
467 CYSTIC FIBROSIS 9 0.0016
468 GOUT 29 0.0016
469 INTRACRANIAL PRESSURE INCREASED 9 0.0016
470 INFUSION SITE EXTRAVASATION 10 0.0016
471 HEPATIC ENZYME ABNORMAL 8 0.0016
472 FACE OEDEMA 27 0.0016
473 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
474 INFLAMMATION 82 0.0016
475 LIVER FUNCTION TEST INCREASED 34 0.0016
476 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
477 AORTIC ANEURYSM 12 0.0016
478 EXPOSURE DURING PREGNANCY 98 0.0016
479 NEUROLOGICAL SYMPTOM 9 0.0016
480 OROPHARYNGEAL DISCOMFORT 14 0.0015
481 TACHYPNOEA 21 0.0015
482 DRUG SPECIFIC ANTIBODY PRESENT 10 0.0015
483 APLASTIC ANAEMIA 8 0.0015
484 DELIRIUM 53 0.0015
485 IMMUNE SYSTEM DISORDER 20 0.0015
486 BLOOD ALBUMIN DECREASED 12 0.0015
487 CARDIAC FAILURE ACUTE 10 0.0015
488 SKIN REACTION 21 0.0015
489 NEUROPATHY PERIPHERAL 141 0.0015
490 DISEASE PROGRESSION 175 0.0015
491 SHOCK 34 0.0015
492 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
493 COLITIS ULCERATIVE 66 0.0015
494 INTENTIONAL DOSE OMISSION 42 0.0015
495 EYELID OEDEMA 17 0.0015
496 ESCHERICHIA INFECTION 12 0.0015
497 HYPOKALAEMIA 67 0.0015
498 LUNG DISORDER 71 0.0014
499 PLEURAL EFFUSION 88 0.0014
500 SYNOVITIS 26 0.0014
501 OFF LABEL USE 1253 0.0014
502 DERMATITIS ALLERGIC 18 0.0014
503 COUGH 401 0.0014
504 BONE MARROW FAILURE 29 0.0014
505 PAPULE 10 0.0014
506 MYOPATHY 12 0.0014
507 CARDIAC MURMUR 12 0.0014
508 DERMATITIS BULLOUS 10 0.0014
509 DYSPNOEA EXERTIONAL 52 0.0014
510 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 72 0.0014
511 RENAL FAILURE 183 0.0014
512 PULMONARY CONGESTION 18 0.0014
513 ATAXIA 16 0.0013
514 HYPERKALAEMIA 47 0.0013
515 ANAEMIA 253 0.0013
516 EMBOLISM 11 0.0013
517 ROTATOR CUFF SYNDROME 17 0.0013
518 SUDDEN DEATH 14 0.0013
519 RASH ERYTHEMATOUS 63 0.0013
520 BLOOD UREA INCREASED 22 0.0013
521 LARYNGEAL OEDEMA 8 0.0013
522 LYMPHOMA 20 0.0013
523 HYPOMAGNESAEMIA 18 0.0013
524 TENDONITIS 20 0.0013
525 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
526 SCAR 22 0.0013
527 DRY THROAT 13 0.0013
528 ANURIA 11 0.0013
529 SEASONAL ALLERGY 18 0.0013
530 BLOOD CREATININE INCREASED 83 0.0013
531 PYELONEPHRITIS 11 0.0013
532 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
533 VISUAL ACUITY REDUCED 42 0.0013
534 PROTEINURIA 24 0.0013
535 HYPONATRAEMIA 71 0.0013
536 TRICUSPID VALVE INCOMPETENCE 10 0.0013
537 DRUG INEFFECTIVE 1645 0.0012
538 MYASTHENIA GRAVIS 10 0.0012
539 RASH PUSTULAR 9 0.0012
540 POLYURIA 10 0.0012
541 HYPOGAMMAGLOBULINAEMIA 8 0.0012
542 HYPOPHAGIA 31 0.0012
543 RENAL INJURY 36 0.0012
544 TOXICITY TO VARIOUS AGENTS 202 0.0012
545 LIVE BIRTH 10 0.0012
546 HEPATIC ENZYME INCREASED 81 0.0012
547 CARDIOGENIC SHOCK 17 0.0012
548 TROPONIN INCREASED 9 0.0012
549 ACCIDENTAL UNDERDOSE 17 0.0012
550 INTERSTITIAL LUNG DISEASE 57 0.0012
551 PNEUMONITIS 32 0.0012
552 MYOCLONUS 14 0.0012
553 LIVER DISORDER 52 0.0012
554 SEPSIS 128 0.0011
555 DERMATITIS 24 0.0011
556 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
557 CHRONIC KIDNEY DISEASE 87 0.0011
558 AFFECTIVE DISORDER 9 0.0011
559 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
560 ANKYLOSING SPONDYLITIS 15 0.0011
561 HAEMORRHAGE INTRACRANIAL 17 0.0011
562 CELLULITIS 57 0.0011
563 DIALYSIS 16 0.0011
564 GENERAL PHYSICAL HEALTH DETERIORATION 130 0.0011
565 ELECTROLYTE IMBALANCE 13 0.0011
566 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 8 0.0011
567 BLOOD SODIUM DECREASED 21 0.0011
568 MUSCLE DISORDER 9 0.0011
569 MYELOSUPPRESSION 40 0.0011
570 HEART RATE IRREGULAR 25 0.0011
571 GASTROINTESTINAL PAIN 12 0.0011
572 ACUTE CORONARY SYNDROME 9 0.0011
573 ANOREXIA 14 0.0011
574 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
575 PSYCHOTIC DISORDER 32 0.0011
576 HYPOPHOSPHATAEMIA 8 0.0011
577 RASH PRURITIC 58 0.0011
578 ARTERIOSCLEROSIS 10 0.0011
579 MITRAL VALVE INCOMPETENCE 12 0.0011
580 VOMITING 497 0.0011
581 SINUS TACHYCARDIA 15 0.0011
582 HYPERCALCAEMIA 13 0.0011
583 HYPOXIA 37 0.0010
584 THERAPEUTIC PRODUCT EFFECT DECREASED 47 0.0010
585 SKIN DISCOLOURATION 48 0.0010
586 RASH GENERALISED 27 0.0010
587 BLINDNESS 42 0.0010
588 TACHYCARDIA 91 0.0010
589 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 30 0.0010
590 HAEMATOCRIT DECREASED 20 0.0010
591 OESOPHAGITIS 11 0.0010
592 PULMONARY OEDEMA 45 0.0010
593 HYPERLIPIDAEMIA 12 0.0010
594 DECREASED APPETITE 233 0.0010
595 HYPOTHYROIDISM 32 0.0010
596 DIPLOPIA 26 0.0010
597 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
598 MIOSIS 8 0.0010
599 VENTRICULAR FIBRILLATION 11 0.0010
600 MULTI-ORGAN FAILURE 17 0.0010
601 OXYGEN SATURATION DECREASED 55 0.0010
602 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
603 WEIGHT DECREASED 272 0.0010
604 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
605 VENTRICULAR TACHYCARDIA 16 0.0010
606 NEPHROPATHY 9 0.0010
607 HEMIPLEGIA 8 0.0010
608 FUNGAL INFECTION 32 0.0010
609 OEDEMA 52 0.0010
610 UVEITIS 13 0.0010
611 BLOOD PRESSURE FLUCTUATION 23 0.0010
612 RECTAL HAEMORRHAGE 41 0.0010
613 RASH 414 0.0009
614 CARDIOMYOPATHY 14 0.0009
615 FOETAL EXPOSURE DURING PREGNANCY 77 0.0009
616 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 67 0.0009
617 SCIATICA 15 0.0009
618 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
619 CHILLS 110 0.0009
620 POST PROCEDURAL COMPLICATION 18 0.0009
621 RESPIRATORY DISORDER 28 0.0009
622 MATERNAL EXPOSURE DURING PREGNANCY 83 0.0009
623 CARDIAC OPERATION 8 0.0009
624 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
625 PLATELET COUNT INCREASED 12 0.0009
626 INFLAMMATORY BOWEL DISEASE 9 0.0009
627 ABDOMINAL PAIN 213 0.0009
628 ADVERSE DRUG REACTION 82 0.0009
629 BEDRIDDEN 12 0.0009
630 INABILITY TO AFFORD MEDICATION 9 0.0009
631 CEREBRAL INFARCTION 22 0.0009
632 OBSTRUCTIVE AIRWAYS DISORDER 10 0.0009
633 JOINT RANGE OF MOTION DECREASED 12 0.0009
634 CARDIOMEGALY 11 0.0009
635 TENDON RUPTURE 11 0.0009
636 INTESTINAL PERFORATION 10 0.0009
637 HYPOTHERMIA 9 0.0009
638 FEEDING DISORDER 18 0.0009
639 PHARYNGITIS 11 0.0009
640 CYST 11 0.0009
641 NAUSEA 698 0.0009
642 PRURITUS 337 0.0009
643 VISUAL IMPAIRMENT 108 0.0009
644 SWELLING 81 0.0009
645 COMA 41 0.0009
646 INFUSION SITE PAIN 11 0.0009
647 MANIA 14 0.0009
648 INSURANCE ISSUE 13 0.0008
649 OROPHARYNGEAL PAIN 78 0.0008
650 MUSCULOSKELETAL CHEST PAIN 13 0.0008
651 CHOLECYSTITIS 10 0.0008
652 GAIT INABILITY 28 0.0008
653 SEIZURE 96 0.0008
654 ADVERSE REACTION 11 0.0008
655 RESTLESS LEGS SYNDROME 15 0.0008
656 THROAT IRRITATION 37 0.0008
657 NOCTURIA 10 0.0008
658 RHINORRHOEA 53 0.0008
659 RESPIRATORY DEPRESSION 10 0.0008
660 SINUS CONGESTION 11 0.0008
661 IMPAIRED GASTRIC EMPTYING 11 0.0008
662 GASTRITIS 21 0.0008
663 INFECTION 115 0.0008
664 ECONOMIC PROBLEM 12 0.0008
665 IMPAIRED DRIVING ABILITY 9 0.0008
666 OSTEOPENIA 12 0.0008
667 ATRIAL FIBRILLATION 77 0.0008
668 SCAB 9 0.0008
669 HAEMATEMESIS 20 0.0008
670 ARTHRITIS 62 0.0008
671 VIRAL INFECTION 26 0.0008
672 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
673 OEDEMA PERIPHERAL 94 0.0008
674 BONE DISORDER 14 0.0008
675 PANIC ATTACK 28 0.0008
676 MUSCULOSKELETAL STIFFNESS 67 0.0008
677 DYSURIA 28 0.0008
678 MOUTH ULCERATION 16 0.0008
679 RASH PAPULAR 17 0.0008
680 BLOOD IRON DECREASED 9 0.0008
681 DYSPNOEA 429 0.0008
682 RESPIRATORY TRACT CONGESTION 12 0.0008
683 GASTROENTERITIS 11 0.0008
684 CHEST DISCOMFORT 77 0.0008
685 HYPOTENSION 150 0.0007
686 SCHIZOPHRENIA 9 0.0007
687 URTICARIA 124 0.0007
688 CARDIAC ARREST 61 0.0007
689 PNEUMONIA 239 0.0007
690 GINGIVAL BLEEDING 10 0.0007
691 ASPIRATION 8 0.0007
692 GASTROINTESTINAL HAEMORRHAGE 61 0.0007
693 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
694 THERAPEUTIC RESPONSE DECREASED 44 0.0007
695 PRESCRIBED OVERDOSE 14 0.0007
696 MYALGIA 122 0.0007
697 LETHARGY 41 0.0007
698 ACUTE MYOCARDIAL INFARCTION 21 0.0007
699 CONFUSIONAL STATE 115 0.0007
700 HAEMOGLOBIN DECREASED 73 0.0007
701 HAEMATOCHEZIA 39 0.0007
702 OSTEOPOROSIS 29 0.0007
703 ABDOMINAL DISCOMFORT 118 0.0007
704 HEPATIC STEATOSIS 13 0.0007
705 FAECES DISCOLOURED 15 0.0007
706 HYPOCALCAEMIA 13 0.0007
707 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
708 VISION BLURRED 94 0.0007
709 DEEP VEIN THROMBOSIS 44 0.0007
710 EYE DISORDER 22 0.0007
711 HYPERSENSITIVITY 124 0.0007
712 HYPERTENSION 141 0.0007
713 PALLOR 18 0.0007
714 DIARRHOEA 426 0.0007
715 COLITIS 25 0.0007
716 BURSITIS 8 0.0007
717 RASH MACULAR 23 0.0007
718 HOSPITALISATION 101 0.0007
719 NO THERAPEUTIC RESPONSE 8 0.0007
720 RESPIRATORY TRACT INFECTION 17 0.0007
721 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
722 UNEVALUABLE EVENT 49 0.0006
723 PRURITUS GENERALISED 14 0.0006
724 ANHEDONIA 17 0.0006
725 WOUND 18 0.0006
726 LABORATORY TEST ABNORMAL 19 0.0006
727 LUNG INFECTION 10 0.0006
728 NERVOUS SYSTEM DISORDER 20 0.0006
729 DEPRESSED LEVEL OF CONSCIOUSNESS 25 0.0006
730 PULMONARY EMBOLISM 60 0.0006
731 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
732 HALLUCINATION, AUDITORY 10 0.0006
733 ULCER 10 0.0006
734 PERITONITIS 13 0.0006
735 COLD SWEAT 11 0.0006
736 ASTHENIA 234 0.0006
737 EPILEPSY 19 0.0006
738 ILLNESS 64 0.0006
739 ANAPHYLACTIC SHOCK 16 0.0006
740 HYPOKINESIA 9 0.0006
741 SKIN ULCER 16 0.0006
742 ANAPHYLACTIC REACTION 34 0.0006
743 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
744 LIMB DISCOMFORT 19 0.0006
745 ANGIOEDEMA 27 0.0006
746 BLISTER 34 0.0006
747 JOINT SWELLING 73 0.0006
748 CYTOMEGALOVIRUS INFECTION 10 0.0006
749 EPISTAXIS 45 0.0006
750 RESTLESSNESS 22 0.0006
751 PNEUMONIA ASPIRATION 15 0.0006
752 SKIN DISORDER 20 0.0006
753 BLOOD POTASSIUM DECREASED 18 0.0006
754 PERICARDITIS 10 0.0006
755 ANGINA PECTORIS 17 0.0006
756 DRUG TOXICITY 8 0.0006
757 CEREBRAL HAEMORRHAGE 21 0.0006
758 PHOTOPHOBIA 11 0.0006
759 HYPOACUSIS 25 0.0006
760 HAEMATOMA 15 0.0006
761 PARAESTHESIA 91 0.0006
762 NEURALGIA 14 0.0006
763 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
764 LIP SWELLING 19 0.0006
765 ARTHRALGIA 237 0.0006
766 DYSPEPSIA 56 0.0006
767 LYMPHOCYTE COUNT DECREASED 10 0.0006
768 OBESITY 9 0.0006
769 HEAD DISCOMFORT 10 0.0006
770 APHASIA 17 0.0006
771 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
772 SENSORY DISTURBANCE 9 0.0006
773 INFLUENZA LIKE ILLNESS 46 0.0006
774 PARALYSIS 8 0.0006
775 PAIN OF SKIN 15 0.0006
776 SKIN EXFOLIATION 47 0.0006
777 WHEEZING 33 0.0006
778 HEART RATE INCREASED 55 0.0006
779 BLOOD POTASSIUM INCREASED 9 0.0006
780 DYSGEUSIA 41 0.0006
781 MENTAL DISORDER 24 0.0006
782 ABDOMINAL PAIN UPPER 113 0.0005
783 CYTOKINE RELEASE SYNDROME 11 0.0005
784 COVID-19 96 0.0005
785 MOBILITY DECREASED 39 0.0005
786 BURNING SENSATION 38 0.0005
787 HEART RATE DECREASED 19 0.0005
788 BRONCHITIS 40 0.0005
789 BODY TEMPERATURE INCREASED 11 0.0005
790 INTENTIONAL PRODUCT USE ISSUE 47 0.0005
791 HYPOGLYCAEMIA 26 0.0005
792 ORAL PAIN 12 0.0005
793 ERYTHEMA 110 0.0005
794 PRESYNCOPE 13 0.0005
795 FEBRILE NEUTROPENIA 35 0.0005
796 PRODUCT AVAILABILITY ISSUE 12 0.0005
797 HIP ARTHROPLASTY 8 0.0005
798 GASTROOESOPHAGEAL REFLUX DISEASE 42 0.0005
799 FEAR 14 0.0005
800 FREQUENT BOWEL MOVEMENTS 14 0.0005
801 ABDOMINAL DISTENSION 54 0.0005
802 ERUCTATION 10 0.0005
803 ECZEMA 27 0.0005
804 RETCHING 11 0.0005
805 LIMB INJURY 14 0.0005
806 POOR QUALITY SLEEP 11 0.0005
807 VERTIGO 31 0.0005
808 HERPES ZOSTER 29 0.0005
809 ARTHROPATHY 28 0.0005
810 POLLAKIURIA 21 0.0005
811 GAIT DISTURBANCE 96 0.0005
812 DIABETES MELLITUS 38 0.0005
813 CHEST PAIN 92 0.0005
814 LOCALISED INFECTION 12 0.0005
815 CORONARY ARTERY DISEASE 15 0.0005
816 OSTEOARTHRITIS 21 0.0005
817 DYSPHAGIA 47 0.0005
818 PRODUCT USE ISSUE 93 0.0005
819 HYPOAESTHESIA 74 0.0005
820 FATIGUE 379 0.0005
821 SLEEP DISORDER 34 0.0005
822 PULMONARY HYPERTENSION 10 0.0005
823 DISORIENTATION 19 0.0005
824 SURGERY 28 0.0005
825 SWELLING FACE 31 0.0005
826 PSORIASIS 62 0.0005
827 MALAISE 205 0.0005
828 HAEMATURIA 16 0.0005
829 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
830 ADVERSE EVENT 43 0.0005
831 PRODUCT DOSE OMISSION ISSUE 137 0.0005
832 UNRESPONSIVE TO STIMULI 12 0.0005
833 ARRHYTHMIA 22 0.0005
834 PRODUCT PRESCRIBING ERROR 11 0.0005
835 ORAL HERPES 9 0.0005
836 MUSCULOSKELETAL PAIN 24 0.0005
837 NEPHROLITHIASIS 21 0.0005
838 CHOLELITHIASIS 15 0.0005
839 INSOMNIA 121 0.0005
840 GYNAECOMASTIA 14 0.0005
841 TREMOR 75 0.0005
842 BLOOD PRESSURE INCREASED 69 0.0005
843 HALLUCINATION 34 0.0005
844 CARDIAC FAILURE 36 0.0004
845 SUICIDAL IDEATION 41 0.0004
846 DISTURBANCE IN ATTENTION 24 0.0004
847 SOMNOLENCE 89 0.0004
848 PLATELET COUNT DECREASED 47 0.0004
849 URINARY INCONTINENCE 13 0.0004
850 RIB FRACTURE 9 0.0004
851 BLOOD PRESSURE DECREASED 29 0.0004
852 DEVICE ISSUE 39 0.0004
853 WEIGHT INCREASED 97 0.0004
854 HEADACHE 271 0.0004
855 CONJUNCTIVITIS 8 0.0004
856 MUSCULAR WEAKNESS 49 0.0004
857 BACK PAIN 100 0.0004
858 RENAL DISORDER 20 0.0004
859 MIDDLE INSOMNIA 8 0.0004
860 DEHYDRATION 57 0.0004
861 EYE PAIN 24 0.0004
862 ANXIETY 121 0.0004
863 DYSARTHRIA 16 0.0004
864 INTESTINAL OBSTRUCTION 16 0.0004
865 DIZZINESS 211 0.0004
866 EATING DISORDER 9 0.0004
867 LOSS OF CONSCIOUSNESS 54 0.0004
868 PSORIATIC ARTHROPATHY 17 0.0004
869 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
870 MEDICATION ERROR 23 0.0004
871 MENTAL IMPAIRMENT 10 0.0004
872 INFLUENZA 46 0.0004
873 ILL-DEFINED DISORDER 25 0.0004
874 ACCIDENTAL OVERDOSE 15 0.0004
875 AGITATION 30 0.0004
876 CYSTITIS 13 0.0004
877 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
878 FLATULENCE 23 0.0004
879 DISABILITY 8 0.0004
880 PAIN 248 0.0004
881 SNEEZING 9 0.0004
882 RHEUMATOID ARTHRITIS 45 0.0004
883 PERIPHERAL SWELLING 61 0.0004
884 IMPAIRED HEALING 13 0.0004
885 STOMATITIS 24 0.0004
886 DRY MOUTH 32 0.0004
887 NEUTROPHIL COUNT DECREASED 16 0.0004
888 NASAL CONGESTION 23 0.0004
889 SYNCOPE 39 0.0004
890 DEPRESSION 88 0.0004
891 HALLUCINATION, VISUAL 8 0.0004
892 NO ADVERSE EVENT 68 0.0004
893 CARDIAC FAILURE CONGESTIVE 30 0.0004
894 DEVICE LEAKAGE 16 0.0004
895 INTENTIONAL PRODUCT MISUSE 32 0.0004
896 HYPERHIDROSIS 47 0.0004
897 LACRIMATION INCREASED 11 0.0004
898 URINARY TRACT INFECTION 62 0.0004
899 SUICIDE ATTEMPT 22 0.0004
900 DISCOMFORT 22 0.0004
901 CARDIO-RESPIRATORY ARREST 15 0.0004
902 BALANCE DISORDER 31 0.0004
903 WITHDRAWAL SYNDROME 15 0.0004
904 ABDOMINAL PAIN LOWER 9 0.0004
905 INJURY 25 0.0004
906 FEMUR FRACTURE 11 0.0004
907 HAEMORRHAGE 37 0.0004
908 PAIN IN JAW 10 0.0004
909 NASOPHARYNGITIS 65 0.0004
910 THERAPY CESSATION 18 0.0004
911 ERECTILE DYSFUNCTION 9 0.0004
912 MUSCLE TWITCHING 8 0.0003
913 DYSSTASIA 10 0.0003
914 PALPITATIONS 40 0.0003
915 DIABETIC KETOACIDOSIS 8 0.0003
916 THROAT TIGHTNESS 9 0.0003
917 URINARY RETENTION 11 0.0003
918 HYPERGLYCAEMIA 12 0.0003
919 PROCEDURAL PAIN 9 0.0003
920 COGNITIVE DISORDER 15 0.0003
921 CATARACT 19 0.0003
922 PAIN IN EXTREMITY 94 0.0003
923 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 57 0.0003
924 MOOD SWINGS 10 0.0003
925 SINUSITIS 32 0.0003
926 HIP FRACTURE 10 0.0003
927 DRUG DOSE OMISSION BY DEVICE 24 0.0003
928 MUCOSAL INFLAMMATION 8 0.0003
929 NECK PAIN 17 0.0003
930 EMOTIONAL DISTRESS 36 0.0003
931 TYPE 2 DIABETES MELLITUS 10 0.0003
932 OVERDOSE 64 0.0003
933 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
934 EYE SWELLING 11 0.0003
935 DYSKINESIA 12 0.0003
936 MOOD ALTERED 8 0.0003
937 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
938 ASTHMA 33 0.0003
939 NERVOUSNESS 15 0.0003
940 HEAD INJURY 9 0.0003
941 FEELING ABNORMAL 68 0.0003
942 MIGRAINE 27 0.0003
943 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
944 FALL 93 0.0003
945 BLOOD CHOLESTEROL INCREASED 13 0.0003
946 HOT FLUSH 21 0.0003
947 CRYING 10 0.0003
948 INFUSION RELATED REACTION 18 0.0003
949 IRRITABILITY 16 0.0003
950 BRADYCARDIA 14 0.0003
951 FEELING HOT 16 0.0003
952 CONTUSION 25 0.0003
953 VAGINAL HAEMORRHAGE 11 0.0003
954 ABNORMAL BEHAVIOUR 10 0.0003
955 CONSTIPATION 55 0.0003
956 ABORTION SPONTANEOUS 10 0.0002
957 UNDERDOSE 18 0.0002
958 FLUSHING 25 0.0002
959 MUSCLE SPASMS 45 0.0002
960 INCORRECT DOSE ADMINISTERED 54 0.0002
961 FLUID RETENTION 12 0.0002
962 DEATH 203 0.0002
963 PRODUCT DOSE OMISSION 15 0.0002
964 CONVULSION 13 0.0002
965 DEPRESSED MOOD 12 0.0002
966 DRY SKIN 30 0.0002
967 CEREBROVASCULAR ACCIDENT 38 0.0002
968 ALOPECIA 42 0.0002
969 MYOCARDIAL INFARCTION 37 0.0002
970 OCULAR HYPERAEMIA 10 0.0002
971 CARDIAC DISORDER 19 0.0002
972 AMNESIA 13 0.0002
973 THROMBOSIS 16 0.0002
974 MEMORY IMPAIRMENT 27 0.0002
975 BLOOD GLUCOSE DECREASED 9 0.0002
976 DRUG EFFECT DECREASED 10 0.0002
977 BLOOD GLUCOSE INCREASED 33 0.0002
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
979 BONE PAIN 10 0.0002
980 DRUG WITHDRAWAL SYNDROME 14 0.0002
981 ACNE 12 0.0002
982 INTENTIONAL OVERDOSE 10 0.0002
983 DERMATITIS ATOPIC 8 0.0002
984 DRUG DEPENDENCE 23 0.0001
985 EYE IRRITATION 8 0.0001
986 INJECTION SITE HAEMORRHAGE 11 0.0001
987 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
988 PRODUCT QUALITY ISSUE 17 0.0001
989 INJECTION SITE PAIN 35 0.0001
990 DEVICE MALFUNCTION 8 0.0001
991 INJECTION SITE BRUISING 9 0.0001
992 DRUG DOSE OMISSION 17 0.0001
993 INJECTION SITE ERYTHEMA 12 0.0001